Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT03875573 |
Title | Neo-adjuvant Chemotherapy Combined With Stereotactic Body Radiotherapy to the Primary Tumour +/- Durvalumab, +/- Oleclumab in Luminal B Breast Cancer: (Neo-CheckRay) |
Acronym | Neo-CheckRay |
Recruitment | Active, not recruiting |
Gender | female |
Phase | Phase II |
Variant Requirements | No |
Sponsors | Jules Bordet Institute |
Indications | |
Therapies | |
Age Groups: | adult | senior |
Covered Countries | FRA | BEL |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
Institut Jules Bordet | Bruxelles | 1000 | Belgium | Details | ||
Cliniques Universitaires Saint-Luc | Bruxelles | 1200 | Belgium | Details | ||
Universitaire Ziekenhuizen | Leuven | 3000 | Belgium | Details | ||
CHU UCL Namur Sainte-Elisabeth | Namur | 5000 | Belgium | Details | ||
GZA - Ziekenhuizen (Campus St. Augustinus) | Wilrijk | 2610 | Belgium | Details | ||
Centre Georges François Leclerc | Dijon | 21079 | France | Details | ||
Institut Curie | Paris | 75248 | France | Details |